Back to Search

HARLAN WEISMAN, M.D.

M.D.

Cardiovascular Disease Physician

NPI: 1619147410Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

25MA07675900(NJ)
Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

MD-041616-L(PA)25MA07675900(NJ)

Research & Publications (3)

Antagonism of E2F-1 regulated Bnip3 transcription by NF-kappaB is essential for basal cell survival.
PMID 19088195·Proc Natl Acad Sci U S A·2008
7-preclinical
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.
PMID 11419888·J Am Coll Cardiol·2001
8-other
Therapeutic heparin concentrations augment platelet reactivity: implications for the pharmacologic assessment of the glycoprotein IIb/IIIa antagonist abciximab.
PMID 10740154·Am Heart J·2000
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
14 CANAL ST
NEW HOPE, PA 18938

Location

Practice Location

14 CANAL ST, NEW HOPE, PA
(908) 432-5937

Quick Facts

NPI
1619147410
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
3

Are you this provider?

Claim Your Profile